Fintech▲ 60

Dyne Therapeutics to Present at AMCP Conference

Globenewswire·April 1, 2026 at 11:30 AM

Dyne Therapeutics will participate in the 2026 Academy of Managed Care Pharmacy (AMCP) Conference. The company plans to present findings from its DELIVER clinical trial, focusing on Duchenne muscular dystrophy (DMD). This presentation aims to shape the future access strategy for potential neuromuscular medicines in the U.S. by contextualizing observed clinical measures and demonstrating the therapeutic value of their treatments.

Dyne Therapeutics to Present at AMCP Conference

Companies Balance AI Opportunities With Fear of Bubble

Sona Secures $45 Million for AI Platform Expansion

Tariffs Reshape Business Strategy One Year Later

eToro launches crypto trading in New York